Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1309572

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1309572

Asia Pacific Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service, By End User, By Technology, By Application, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 127 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Asia Pacific Point of Care Molecular Diagnostics Market would witness market growth of 10.7% CAGR during the forecast period (2023-2030).

The market is seeing significant growth in a major trend called technological innovation. Major players in the point-of-care molecular diagnostics market are concentrating on offering cutting-edge technology solutions to improve their market position. These businesses are adopting next-generation point-of-care molecular diagnostics technologies and related services, including DNA microarrays, spectral karyotyping imaging, mass spectrometry, enzyme-linked immunosorbent assay (ELISA), PCR, and ELISA, as well as in situ hybridizations, spectral karyotyping imaging, ELISA, and ELISA.

For instance, the molecular point-of-care test for detecting novel COVID-19 (COVID-19) was introduced by Abbott Laboratories, a US-based manufacturer of medical devices, in March 2020. According to the manufacturer, the gadget displays positive findings in five minutes and negative results in thirteen. The ID NOWTM platform, which uses isothermal nucleic acid amplification technology to provide molecular results in a matter of seconds, will be used for this test.

China and Japan are two of the most afflicted Asian nations, and it is projected that Japan's elderly population will rise significantly. More than 20% of the nation's population is over 65. A diversified, heavily populated area with 4.2 billion people, Southern, Eastern, and South-Eastern Asia accounts for 55% of the world's population. As a result, the demand in Asia Pacific is anticipated to increase as a result of the growth in cancer cases, the dearth of sophisticated central laboratory testing facilities, the need for clinical testing among a wider population, and the possibility for PoC molecular assays to be implemented at a reasonable cost.

The China market dominated the Asia Pacific Point of Care Molecular Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $299.2 million by 2030. The Japan market is anticipated grow at a CAGR of 10% during (2023 - 2030). Additionally, The India market would witness a CAGR of 11.4% during (2023 - 2030).

Based on Product & Service, the market is segmented into Assays & Kits, Instruments & Analyzers and Software & Services. Based on End User, the market is segmented into Physicians Offices, Hospitals & ICUs, Research Institutes and Others. Based on by Technology, the market is segmented into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others. Based on Application, the market is segmented into Respiratory Diseases, Hospital-acquired Infections, Sexually Transmitted Diseases, Cancer, Hepatitis, Gastrointestinal Disorders and Others.Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation

Scope of the Study

Market Segments covered in the Report:

by Product & Service

  • Assays & Kits
  • Instruments & Analyzers
  • Software & Services Surveillance & Monitoring

By End User

  • Physicians Offices
  • Hospitals & ICUs
  • Research Institutes
  • Others

By Technology

  • RT-PCR
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

By Application

  • Respiratory Diseases
  • Hospital-acquired Infections
  • Sexually Transmitted Diseases
  • Cancer
  • Hepatitis
  • Gastrointestinal Disorders
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Abbott Laboratories
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Nova Biomedical Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Point of Care Molecular Diagnostics Market, by Product & Service
    • 1.4.2 Asia Pacific Point of Care Molecular Diagnostics Market, by End User
    • 1.4.3 Asia Pacific Point of Care Molecular Diagnostics Market, by Technology
    • 1.4.4 Asia Pacific Point of Care Molecular Diagnostics Market, by Application
    • 1.4.5 Asia Pacific Point of Care Molecular Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service

  • 4.1 Asia Pacific Assays & Kits Market by Country
  • 4.2 Asia Pacific Instruments & Analyzers Market by Country
  • 4.3 Asia Pacific Software & Services Market by Country

Chapter 5. Asia Pacific Point of Care Molecular Diagnostics Market by End User

  • 5.1 Asia Pacific Physicians Offices Market by Country
  • 5.2 Asia Pacific Hospitals & ICUs Market by Country
  • 5.3 Asia Pacific Research Institutes Market by Country
  • 5.4 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Point of Care Molecular Diagnostics Market by Technology

  • 6.1 Asia Pacific RT-PCR Market by Country
  • 6.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
  • 6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Point of Care Molecular Diagnostics Market by Application

  • 7.1 Asia Pacific Respiratory Diseases Market by Country
  • 7.2 Asia Pacific Hospital-acquired Infections Market by Country
  • 7.3 Asia Pacific Sexually Transmitted Diseases Market by Country
  • 7.4 Asia Pacific Cancer Market by Country
  • 7.5 Asia Pacific Hepatitis Market by Country
  • 7.6 Asia Pacific Gastrointestinal Disorders Market by Country
  • 7.7 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Point of Care Molecular Diagnostics Market by Country

  • 8.1 China Point of Care Molecular Diagnostics Market
    • 8.1.1 China Point of Care Molecular Diagnostics Market by Product & Service
    • 8.1.2 China Point of Care Molecular Diagnostics Market by End User
    • 8.1.3 China Point of Care Molecular Diagnostics Market by Technology
    • 8.1.4 China Point of Care Molecular Diagnostics Market by Application
  • 8.2 Japan Point of Care Molecular Diagnostics Market
    • 8.2.1 Japan Point of Care Molecular Diagnostics Market by Product & Service
    • 8.2.2 Japan Point of Care Molecular Diagnostics Market by End User
    • 8.2.3 Japan Point of Care Molecular Diagnostics Market by Technology
    • 8.2.4 Japan Point of Care Molecular Diagnostics Market by Application
  • 8.3 India Point of Care Molecular Diagnostics Market
    • 8.3.1 India Point of Care Molecular Diagnostics Market by Product & Service
    • 8.3.2 India Point of Care Molecular Diagnostics Market by End User
    • 8.3.3 India Point of Care Molecular Diagnostics Market by Technology
    • 8.3.4 India Point of Care Molecular Diagnostics Market by Application
  • 8.4 South Korea Point of Care Molecular Diagnostics Market
    • 8.4.1 South Korea Point of Care Molecular Diagnostics Market by Product & Service
    • 8.4.2 South Korea Point of Care Molecular Diagnostics Market by End User
    • 8.4.3 South Korea Point of Care Molecular Diagnostics Market by Technology
    • 8.4.4 South Korea Point of Care Molecular Diagnostics Market by Application
  • 8.5 Singapore Point of Care Molecular Diagnostics Market
    • 8.5.1 Singapore Point of Care Molecular Diagnostics Market by Product & Service
    • 8.5.2 Singapore Point of Care Molecular Diagnostics Market by End User
    • 8.5.3 Singapore Point of Care Molecular Diagnostics Market by Technology
    • 8.5.4 Singapore Point of Care Molecular Diagnostics Market by Application
  • 8.6 Malaysia Point of Care Molecular Diagnostics Market
    • 8.6.1 Malaysia Point of Care Molecular Diagnostics Market by Product & Service
    • 8.6.2 Malaysia Point of Care Molecular Diagnostics Market by End User
    • 8.6.3 Malaysia Point of Care Molecular Diagnostics Market by Technology
    • 8.6.4 Malaysia Point of Care Molecular Diagnostics Market by Application
  • 8.7 Rest of Asia Pacific Point of Care Molecular Diagnostics Market
    • 8.7.1 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
    • 8.7.2 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User
    • 8.7.3 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology
    • 8.7.4 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 SWOT Analysis
  • 9.2 Bayer AG
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 SWOT Analysis
  • 9.3 Thermo Fisher Scientific, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expenses
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Acquisition and Mergers:
    • 9.3.6 SWOT Analysis
  • 9.4 F. Hoffmann-La Roche Ltd.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
      • 9.4.5.2 Product Launches and Product Expansions:
      • 9.4.5.3 Acquisition and Mergers:
  • 9.5 BioMerieux S.A.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Acquisition and Mergers:
  • 9.6 Qiagen N.V.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
  • 9.7 Danaher Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
  • 9.8 Bio-Rad laboratories, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Acquisition and Mergers:
  • 9.9 Agilent Technologies, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Partnerships, Collaborations, and Agreements:
  • 9.10. Nova Biomedical Corporation
    • 9.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 2 Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Point of Care Molecular Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions- Point of Care Molecular Diagnostics Market
  • TABLE 5 Acquisition and Mergers- Point of Care Molecular Diagnostics Market
  • TABLE 6 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 7 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 8 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
  • TABLE 9 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
  • TABLE 10 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 11 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 12 Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
  • TABLE 13 Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
  • TABLE 14 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 15 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 16 Asia Pacific Physicians Offices Market by Country, 2019 - 2022, USD Million
  • TABLE 17 Asia Pacific Physicians Offices Market by Country, 2023 - 2030, USD Million
  • TABLE 18 Asia Pacific Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
  • TABLE 19 Asia Pacific Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
  • TABLE 20 Asia Pacific Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 21 Asia Pacific Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 22 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 23 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 24 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 25 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 26 Asia Pacific RT-PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 27 Asia Pacific RT-PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 28 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
  • TABLE 29 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
  • TABLE 30 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 31 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 32 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 33 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 34 Asia Pacific Respiratory Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 35 Asia Pacific Respiratory Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 36 Asia Pacific Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
  • TABLE 37 Asia Pacific Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
  • TABLE 38 Asia Pacific Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
  • TABLE 39 Asia Pacific Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
  • TABLE 40 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
  • TABLE 41 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
  • TABLE 42 Asia Pacific Hepatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 43 Asia Pacific Hepatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 44 Asia Pacific Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
  • TABLE 45 Asia Pacific Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
  • TABLE 46 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 47 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 48 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
  • TABLE 49 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
  • TABLE 50 China Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 51 China Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 52 China Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 53 China Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 54 China Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 55 China Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 56 China Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 57 China Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 58 China Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 59 China Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 60 Japan Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 61 Japan Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 62 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 63 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 64 Japan Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 65 Japan Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 66 Japan Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 67 Japan Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 68 Japan Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 69 Japan Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 70 India Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 71 India Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 72 India Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 73 India Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 74 India Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 75 India Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 76 India Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 77 India Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 78 India Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 79 India Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 80 South Korea Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 81 South Korea Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 82 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 83 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 84 South Korea Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 85 South Korea Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 86 South Korea Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 87 South Korea Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 88 South Korea Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 89 South Korea Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 90 Singapore Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 91 Singapore Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 92 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 93 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 94 Singapore Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 95 Singapore Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 96 Singapore Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 97 Singapore Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 98 Singapore Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 99 Singapore Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 100 Malaysia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 101 Malaysia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 102 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 103 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 104 Malaysia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 105 Malaysia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 106 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 107 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 108 Malaysia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 109 Malaysia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 110 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 111 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 112 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 113 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 114 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 115 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 116 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
  • TABLE 117 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
  • TABLE 118 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
  • TABLE 119 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
  • TABLE 120 Key Information - Abbott Laboratories
  • TABLE 121 Key Information - Bayer AG
  • TABLE 122 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 123 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 124 Key information - BioMerieux S.A.
  • TABLE 125 Key Information - Qiagen N.V.
  • TABLE 126 Key Information - Danaher Corporation
  • TABLE 127 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 128 key Information - Agilent Technologies, Inc.
  • TABLE 129 key information - Nova Biomedical Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 4 Asia Pacific Point of Care Molecular Diagnostics Market share by Product & Service, 2022
  • FIG 5 Asia Pacific Point of Care Molecular Diagnostics Market share by Product & Service, 2030
  • FIG 6 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
  • FIG 7 Asia Pacific Point of Care Molecular Diagnostics Market share by End User, 2022
  • FIG 8 Asia Pacific Point of Care Molecular Diagnostics Market share by End User, 2030
  • FIG 9 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
  • FIG 10 Asia Pacific Point of Care Molecular Diagnostics Market share by Technology, 2022
  • FIG 11 Asia Pacific Point of Care Molecular Diagnostics Market share by Technology, 2030
  • FIG 12 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
  • FIG 13 Asia Pacific Point of Care Molecular Diagnostics Market share by Application, 2022
  • FIG 14 Asia Pacific Point of Care Molecular Diagnostics Market share by Application, 2030
  • FIG 15 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
  • FIG 16 Asia Pacific Point of Care Molecular Diagnostics Market share by Country, 2022
  • FIG 17 Asia Pacific Point of Care Molecular Diagnostics Market share by Country, 2030
  • FIG 18 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2019 - 2030, USD Million
  • FIG 19 Swot Analysis: Abbott Laboratories
  • FIG 20 Swot Analysis: Bayer AG
  • FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
  • FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!